Stacy Lawrence


Stacy has been writing and editing about the business of emerging technologies for more than 15 years. Most recently, she was the biopharma business bureau editor with Elsevier. Prior to that, she was the finance columnist with biotechnology industry publication BioCentury. Stacy also has written for publications including Nature Biotechnology, San Francisco Business Times, New Scientist, MIT Technology Review, Business 2.0, and Wired. Stacy can be reached at [email protected]